IKZF1 and Miyoshi myopathy: Cellular assays have validated that TMX-4116 significantly degrades CK1α in acute lymphoblastic leukemia cells (MOLT4), human T lymphoblast cells (Jurkat), and MM cells (MM.1S), without affecting PDE6D, IKZF1, and IKZF3 (99).